Back

Left-ventricular-only cardiac resynchronization therapy with electrocardiographic optimization: 100-day follow-up

7 April 2024 (08:30 - 15:00)
Organised by: Logo
Congress Presentation Part of: Poster session on devices, others Cardiac Resynchronisation Therapy (CRT) EHRA Premium Access EHRA 2024 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Professor Tran Thong

Hue university of medicine and pharmacy, Hue (Viet Nam)

108 More presentations in this session

Presentation thumbnail
Emergency leadless pacing implantation is feasible and safe out-of-hours
Doctor F. O'Rourke (London, GB)
Abstract Slides Video
Presentation thumbnail
Outcomes of subcutaneous implantable cardioverter defibrillators: UK tertiary centre experience
Doctor L. Toon (Southampton, GB)
Abstract Slides Video
Presentation thumbnail
Evaluation of the quality of life of patients with leadless pacing system during 1 year follow-up period
Doctor A. Baimbetov (Almaty, KZ)
Abstract Slides
Presentation thumbnail
Which paced QRS duration can be achieved in selective and non-selective His bundle pacing?
Mr C. Israel (Bielefeld, DE)
Abstract Slides Video
Presentation thumbnail
Procedural heart rate variability and its effect on short-term symptoms after cardioneuromodulation procedure
Doctor S. AYGUN (Ankara, TR)
Abstract

Access the full session

Session thumbnail
Poster session on devices, others

The Event

Event poster

EHRA 2024

7 April - 9 April 2024
You may be interested in
thumbnail
Congress Presentation
Optimising electrical performance of leadless cardiac resynchronisation therapy and leadless LV septal pacing
thumbnail
Congress Presentation
Left bundle branch area pacing optimized cardiac resynchronization therapy ( LOT CRT) -comparative results to a CRT implanted patient population
thumbnail
Congress Presentation
Electrocardiographic predictors of haemodynamic benefit from biventricular pacing: the role of atrioventricular timing measures

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources